December 3, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE: | Medigus Ltd. (CIK 0001618500) | |
Post-Effective Amendment Withdrawal Request Registration Statement No. 333-249797 |
Ladies and Gentlemen:
Pursuant to Rule 477(a) of the Securities Act of 1933, as amended (the “Securities Act”), Medigus Ltd., hereby requests the withdrawal of Post-Effective Amendment No. 1 to the Registration Statement on Form F-1 (the “Post-Effective Amendment”), Registration Statement No. 333-249797, filed on December 2, 2020. The Post-Effective Amendment was inadvertently filed without checking off the box to reflect that this Post-Effective Amendment was filed pursuant to Rule 462(d) of the Securities Act. We wish to withdraw the Post-Effective Amendment to correct this error. Simultaneous with the submission of this letter, we will be filing a revised Post-Effective Amendment solely to rectify the EDGAR filing error specified above.
We appreciate your assistance in this matter.
Very truly yours, | ||
MEDIGUS LTD. | ||
By: | /s/ Tatiana Yosef | |
Tatiana Yosef Chief Financial Officer |
Suite 7A, Industrial Park, POB 3030, Omer, 8496500, Israel
T: +972-8-6466880 / F: +972-8-6466770 / E: info@medigus.com